These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 6858771

  • 1. Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease.
    Stern GM, Lees AJ.
    Adv Neurol; 1983; 37():17-21. PubMed ID: 6858771
    [Abstract] [Full Text] [Related]

  • 2. Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease.
    Lees AJ, Stern GM.
    J Neurol Neurosurg Psychiatry; 1981 Nov; 44(11):1020-3. PubMed ID: 7334388
    [Abstract] [Full Text] [Related]

  • 3. [Bromocriptine as the 1st treatment of Parkinson's disease. Long term results].
    Rascol A, Montastruc JL, Guiraud-Chaumeil B, Clanet M.
    Rev Neurol (Paris); 1982 Nov; 138(5):401-8. PubMed ID: 7146724
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
    Montastruc JL, Rascol O, Rascol A.
    Rev Neurol (Paris); 1990 Nov; 146(2):144-7. PubMed ID: 2181588
    [Abstract] [Full Text] [Related]

  • 5. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
    Grimes JD, Delgado MR.
    Clin Neuropharmacol; 1985 Nov; 8(1):73-7. PubMed ID: 3978651
    [Abstract] [Full Text] [Related]

  • 6. Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.
    Jansen EN, Meerwaldt JD.
    Adv Neurol; 1987 Nov; 45():539-42. PubMed ID: 3103396
    [Abstract] [Full Text] [Related]

  • 7. An evaluation of bromocriptine in the treatment of Parkinson's disease.
    Mackenzie RA, Lance JW.
    Clin Exp Neurol; 1978 Nov; 15():228-36. PubMed ID: 386307
    [Abstract] [Full Text] [Related]

  • 8. Low-dose bromocriptine in the early phases of Parkinson's disease.
    Tolosa E, Blesa R, Bayes A, Forcadell F.
    Clin Neuropharmacol; 1987 Apr; 10(2):168-74. PubMed ID: 3332610
    [Abstract] [Full Text] [Related]

  • 9. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
    Im JH, Ha JH, Cho IS, Lee MC.
    J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999
    [Abstract] [Full Text] [Related]

  • 10. A nation-wide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. First interim report in Japan.
    Nakanishi T, Mizuno Y, Goto I, Iwata M, Kanazawa I, Kowa H, Mannen T, Nishitani H, Ogawa N, Takahashi A.
    Eur Neurol; 1988 Jan; 28 Suppl 1():3-8. PubMed ID: 3378560
    [Abstract] [Full Text] [Related]

  • 11. Bromocriptine: long-term low-dose therapy in Parkinson's disease.
    Teychenne PF, Bergsrud D, Elton RL, Racy A.
    Clin Neuropharmacol; 1986 Jan; 9(2):138-45. PubMed ID: 3708599
    [Abstract] [Full Text] [Related]

  • 12. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
    Castro-Caldas A, Delwaide P, Jost W, Merello M, Williams A, Lamberti P, Aguilar M, Del Signore S, Cesaro P, Parkinson-Control Study Group.
    Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842
    [Abstract] [Full Text] [Related]

  • 13. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
    Hauser RA, Koller WC, Hubble JP, Malapira T, Busenbark K, Olanow CW.
    Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
    [Abstract] [Full Text] [Related]

  • 14. Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
    Lieberman AN, Neophytides A, Leibowitz M, Gopinathan G, Pact V, Walker R, Goodgold A, Goldstein M.
    Adv Neurol; 1983 May; 37():95-108. PubMed ID: 6858782
    [Abstract] [Full Text] [Related]

  • 15. [Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
    Fischer PA, Przuntek H, Majer M, Welzel D.
    Dtsch Med Wochenschr; 1984 Aug 24; 109(34):1279-83. PubMed ID: 6381019
    [Abstract] [Full Text] [Related]

  • 16. Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease.
    Gron U.
    Acta Neurol Scand; 1977 Sep 24; 56(3):269-73. PubMed ID: 333855
    [Abstract] [Full Text] [Related]

  • 17. Treatment of parkinson's disease with bromocriptine.
    Lieberman A, Kupersmith M, Estey E, Goldstein M.
    N Engl J Med; 1976 Dec 16; 295(25):1400-4. PubMed ID: 989885
    [Abstract] [Full Text] [Related]

  • 18. Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
    Factor SA, Weiner WJ.
    Mov Disord; 1993 Jul 16; 8(3):257-62. PubMed ID: 8341289
    [Abstract] [Full Text] [Related]

  • 19. The addition of bromocriptine to long-term dopa therapy in Parkinson's disease.
    Selby G.
    Clin Exp Neurol; 1989 Jul 16; 26():129-39. PubMed ID: 2701877
    [Abstract] [Full Text] [Related]

  • 20. Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.
    Pezzoli G, Martignoni E, Pacchetti C, Angeleri VA, Lamberti P, Muratorio A, Bonuccelli U, De Mari M, Foschi N, Cossutta E.
    Mov Disord; 1994 Jul 16; 9(4):431-6. PubMed ID: 7969210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.